Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > 10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - large image1
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - image1
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - image2
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - image3
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - image4
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - image5
10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door buy - image6

10mg vials Tirzepatide CAS2023788-19-2 Lyophilized peptide for Weight Loss 5mg10mg vials door-to-door

TDS 2100 Inquiries

Unit Price:

$48/UNIT EXW

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Tianjin

Brand:

Mingheng

Packaging:

10mg/vial

Sample Available:

Yes

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment
Average Lead Time:
7 days
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Cagrilintide,Semax,Liraglutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    Tirzepatide (LY3298176) is a dual glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

    Tirzepatide, also known as LY 3298176, is a dual glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

    Product Name  Tirzepatide
    Appearance  white powder
    Purity  99%
    CAS
    2023788-19-2
    Storage Cool Dry Place
    Shelf Life 24 months


    Applications:
    Lowers blood sugar: Tirzepatide can promote the secretion and inhibit the secretion of glucagon, thereby effectively lowering blood sugar levels. In clinical trials, Tirzepatide showed more significant hypoglycemic effects than GLP-1 receptor agonists currently on the market.
    Weight Loss: Tirzepatide has also shown significant weight loss effects. Because it suppresses appetite and increases satiety, it can help patients control their diet and reduce calorie intake, thereby achieving weight loss.
    Reduces cardiovascular risk: Tirzepatide has also been shown in clinical trials to reduce the risk of cardiovascular events. This may be due to the combined effect of its ability to lower blood sugar, lower blood pressure, reduce weight, and other factors.

    --Helps slow food leaving your stomach
    --Helps prevent your liver from making too much sugar
    --Can help control blood glucose
    --Can reduce hyperglycemia, especially after meals
    --Can reduce hemoglobin A1c
    --Can decrease appetite and caloric intake, while inhibiting weight gain
    --Has been shown to lower triglyceride levels and oxidative stress from high LDL
    --Has been shown to help induce weight loss in obese patients with higher dosing
    --Helps decrease leptin and increase leptin sensitivity
    --Can increase the conversion of white fat to brown fat

    Product Photo:

    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 1

    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 2

    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 3

    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 4

    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 5


    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 6

    Shop Lyophilized peptide Tirzepatide CAS2023788-19-2 for Weight Loss 5mg10mg vials-Detailed Image 7


      Company Information  


    Haikou Mingheng Biotechnology Co., Ltd, is a pioneering force in the biotechnology sector. At the core of our operations is the unwavering commitment to our guiding principles: "Quality First, Service Supreme."

    Business Philosophy:
    "Quality First, Service Supreme" encapsulates our business philosophy. We firmly believe that prioritizing quality in all aspects of our operations and providing exceptional service form the foundation for enduring success.

    Key Products:
    Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.

    Mission:
    Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

    Customized Peptides:
    In addition to our standard product line, we specialize in crafting customized peptides tailored to meet the unique needs of our diverse clientele.

    Future Vision:
    As we move forward, Haikou Mingheng Biotechnology Co., Ltd. is poised for continued growth and innovation. We are committed to expanding our product portfolio, staying at the forefront of technological advancements, and exceeding the expectations of our valued clients.

    At Haikou Mingheng Biotechnology Co., Ltd, we are not just shaping the future of biotechnology; we are pioneering a path towards a healthier and more sustainable world.

    Shop Lyophilized peptide Semaglutide-Freeze-dried peptide powder for weight control cas910463-68-2 10mg,5mg,15mg-Detailed Image 5

    Shop Lyophilized peptide Semaglutide-Freeze-dried peptide powder for weight control cas910463-68-2 10mg,5mg,15mg-Detailed Image 6


     Certificate 


    Shop Lyophilized peptide Semaglutide-Freeze-dried peptide powder for weight control cas910463-68-2 10mg,5mg,15mg-Detailed Image 7

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Cagrilintide,Semax,Liraglutide

    Location:

    Shop No. 47, Jixin Plaza, No. 26 Renmin Avenue, Renmin Street, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    TT against copy of documents,L/C,TT against B/L draft before shipment

    Average lead Time:

    7 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    11-50

    Year of Establishment:

    2019

    Company Profile

    Haikou Mingheng Biotechnology Co., Ltd.  was established in 2024 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. Effectively promote the joint venture and cooperation with the major enterprises, manufacturers, with the idea of industrial development to serve the society and the majority of users. We always adhere to the market demand as the orientation, constantly synthesizing new high-tech chemical products and medical intermediates, mainly exported to the United States, Europe, India, South Africa, Nigeria and other countries and regions, has a wealth of export experience, to ensure transportation safety, can let each customer as soon as possible to safely receive the goods.


  • Inquiry History
    2100 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Tirzepatide

    20 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    United States

    Tirzepatide

    50 MG Oct 20, 2026
    Spain

    tirzepatide

    20 MG Oct 19, 2026
    United States

    tirzepatide

    30 MG Oct 19, 2026
    Philippines

    tirzepatide

    40 MG Oct 19, 2026
    United States

    tirzepatide

    50 MG Oct 19, 2026
    United States

    tirzepatide

    50 MG Oct 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.